Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04628494 |
|---|---|
| Brief Title: | A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL (EPCORE DLBCL-1) |
| First Submitted : | November 9, 2020 |
| First Submitted that Met QC Criteria : | November 9, 2020 |
| First Posted : | November 13, 2020 |
| Last Update Submitted that Met QC Criteria : | January 9, 2023 |
| Last Update Posted : | January 11, 2023 |